Ahmed, S., Kanakry, J. A., Ahn, K. W., Litovich, C. A., Abdel-Azim, H., Aljurf, M. D., . . . Hamadani, M. (2019). Lower Graft-versus-Host Disease and Relapse Risk in Post-Transplant Cyclophosphamide-Based Haploidentical versus Matched Sibling Donor Reduced-Intensity Conditioning Transplant for Hodgkin Lymphoma.
Citación estilo ChicagoAhmed, Sairah|||0000-0001-7302-8299, et al. Lower Graft-versus-Host Disease and Relapse Risk in Post-Transplant Cyclophosphamide-Based Haploidentical Versus Matched Sibling Donor Reduced-Intensity Conditioning Transplant for Hodgkin Lymphoma. 2019.
Cita MLAAhmed, Sairah|||0000-0001-7302-8299, et al. Lower Graft-versus-Host Disease and Relapse Risk in Post-Transplant Cyclophosphamide-Based Haploidentical Versus Matched Sibling Donor Reduced-Intensity Conditioning Transplant for Hodgkin Lymphoma. 2019.